Skip to main content
. 2021 Apr 19;109(4):383–392. doi: 10.1007/s00223-021-00848-x

Fig. 1.

Fig. 1

Serum total (ALP, a) and bone (BAP, b) alkaline phosphatase levels over time in all patients with Paget’s disease of bone before and after the first infusion of zoledronate. Patients repeating treatment were subsequently excluded from the analysis. Data are represented as mean ± standard error of the mean. *p < 0.05 vs basal values. n number of patients assessed at each time point, nr number of patients with ALP or BAP within reference range at each time point